A Reasonable Response to Diphenylcyclopropenone in Pediatric Alopecia Patient: A Case Report

    July 2021 in “ Clinical case reports and studies ”
    Selma Bakar Dertlıoğlu
    New to Alopecia Areata? There is a guide in the encyclopedia. Read the guide →
    Image
    Studysummary In this case report, a 9-year-old boy with diffuse alopecia areata showed improvement with topical diphencyprone immunotherapy, suggesting it as a safe and effective treatment option in pediatric cases of alopecia areata resistant to other therapies.
    Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
    Alopecia areata (AA) is an autoimmune disorder causing hair loss, with an unpredictable course and unclear etiology. This case report describes a 9-year-old boy with diffuse AA who was treated with topical diphencyprone (DPCP) after other treatments failed. The treatment was effective, easy to administer, and had fewer side effects, making it a preferable option for pediatric patients. The report emphasizes the importance of individualized treatment to improve the quality of life and prevent psychological impairments in children with AA.
    Discuss this study in the Community →

    Research cited in this study

    1 / 1 results